How to Choose a Robotic Surgery System

What hospital procurement committees, ASC administrators, and surgical service-line directors need to know before committing to a multi-million-dollar robotic platform.

What this is and who buys it

Robotic surgery systems are surgeon-controlled, computer-assisted platforms that translate a physician's hand movements into precise micro-motions at the instrument tip inside the patient. A standard soft-tissue configuration consists of three components: a surgeon console, a patient-side cart carrying two to four articulating arms, and a vision/imaging tower. The surgeon operates at the console using haptic controls; the system's software filters tremor and scales motion. The surgeon never directly manipulates the patient, which is why proper training and credentialing are as important as the capital purchase itself.

Buyers are almost always hospital C-suites, surgical service-line directors, and capital equipment committees — often responding to competitive pressure from nearby health systems. Ambulatory surgery centers are an increasingly active segment, particularly for orthopedic and gynecologic procedures as outpatient robotic reimbursement has expanded. With over 6,700 robotic systems installed worldwide and U.S. adoption rates continuing to climb, procurement is as much a strategic decision as a clinical one [S10].

"Robotic surgery system" is not a single product category, and conflating sub-types in one RFP is a common and expensive mistake. Soft-tissue multi-port platforms, single-port systems, and orthopedic bone-cutting robots serve fundamentally different specialties, carry different capital structures, and impose entirely different consumable economics. Clarifying which category your surgeons actually need is the essential first step.

Key decision factors

Procedure mix and specialty fit is the single most consequential variable. Soft-tissue platforms —